We provide you with 20 years of free, institutional-grade data for GANX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GANX. Explore the full financial landscape of GANX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about GANX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Gain Therapeutics, Inc(NASDAQ:GANX) 
Gain Therapeutics, Inc. is a redefining drug discovery company with its proprietary target identification platform. It focuses on identifying and optimizing allosteric binding sites and is unlocking new treatment options for disorders characterized by protein misfolding. The company was founded in 2...
Share this website to your friends